Welcome to the 6th Annual Biomedical Forum. This year’s program will focus on the FDA regulatory issues and the latest innovations in medical device industry, as well as business strategy and opportunities to thrive in the new economy amid global financial challenges. The mission of this forum is to provide an attractive platform for entrepreneurs, scientists, engineers, investors, executives, and policy makers to promote life sciences, biotechnology, pharmaceutical, medical device and alliances across the biomedical industry in Southern California and Asia. The annual biomedical forum is one of the flagship events organized by SABPA OC/LA, which consistently attracted more than 200 attendees. This year, we have brought to you FDA officials and seasoned regulatory affair experts, as well as exhilarating entrepreneurs that help accelerate the development of technology into clinical practices. I hope you will enjoy the program.
Fred Ouyang, PhD, MBA
President, SABPA OC/LA
a:22:{i:0;a:3:{s:12:"time_program";s:7:"8:00 am";s:19:"description_program";s:0:"";s:7:"program";s:34:"Registration
Coffee and Breakfast";}i:1;a:3:{s:12:"time_program";s:7:"9:00 am";s:19:"description_program";s:50:"Fred Ouyang, PhD, MBA
President, SABPA OC/LA";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:9:"Session 1";s:19:"description_program";s:116:"Moderator: Peter Chen PhD
President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.";s:7:"program";s:28:"Innovation in Medical Device";}i:3;a:3:{s:12:"time_program";s:7:"9:15 am";s:19:"description_program";s:69:"Thomas Yuen
Chairman and CEO, SRS Labs, Biomedical Entrepreneur";s:7:"program";s:90:"Exploring the therapeutic application of stem cell technology: an entrepreneur’s journey";}i:4;a:3:{s:12:"time_program";s:8:"10:00 am";s:19:"description_program";s:69:"Fred Tzeng, PhD
President and Co-founder, ZeroWatt Technologies";s:7:"program";s:65:"Commercialization of University Research by a Former Grad Student";}i:5;a:3:{s:12:"time_program";s:8:"10:20 am";s:19:"description_program";s:0:"";s:7:"program";s:5:"Break";}i:6;a:3:{s:12:"time_program";s:8:"10:40 am";s:19:"description_program";s:96:"Paul Chen, MD
Entrepreneur and Eye Surgeon, North County Laser Eye Associates at San Diego";s:7:"program";s:62:"JET Lasik, accelerating ocular healing by cell transplantation";}i:7;a:3:{s:12:"time_program";s:8:"11:00 am";s:19:"description_program";s:50:"Steve Wheeler
Director of Sales, IDEAL LIFE ";s:7:"program";s:90:"The World-Wide Opportunities for Customized Wireless Monitoring with Real Time Data Access";}i:8;a:3:{s:12:"time_program";s:8:"11:20 am";s:19:"description_program";s:56:"Nadine Ding, PhD
Fellow at Abbott Vascular Devices";s:7:"program";s:87:"Drug Eluting Stent, a Combination Product of Drug and Device and Its Regulatory Pathway";}i:9;a:3:{s:12:"time_program";s:8:"11:40 am";s:19:"description_program";s:0:"";s:7:"program";s:23:"Lunch and Exhibit Booth";}i:10;a:3:{s:12:"time_program";s:10:"Session II";s:19:"description_program";s:80:"Moderator: Jinsong Ni, PhD.
Director, Drug Safety Evaluation, Allergan Inc";s:7:"program";s:8:"Industry";}i:11;a:3:{s:12:"time_program";s:8:"1: 00 pm";s:19:"description_program";s:91:"Edwards Sydney
Senior Director, Portfolio Management and Strategic Planning, Allergan";s:7:"program";s:62:"Global Project & Portfolio Management: The Allergan Experience";}i:12;a:3:{s:12:"time_program";s:7:"1:20 pm";s:19:"description_program";s:51:"Sabing Lee, JD, Knobbe, Martens, Olson & Bear, LLP ";s:7:"program";s:102:"Important Developments in Intellectual Property Affecting the Biomedical and Pharmaceutical Industries";}i:13;a:3:{s:12:"time_program";s:7:"1:40 pm";s:19:"description_program";s:72:"Jerry Hefner, Ph.D., J.D.
Partner, Knobbe Martens Olson & Bear LLP";s:7:"program";s:65:"Potential Changes in the Patentability of Life Science Inventions";}i:14;a:3:{s:12:"time_program";s:7:"2:00 pm";s:19:"description_program";s:76:"Abe Lee
Chair and Professor, Department of Biomedical Engineering, UCI";s:7:"program";s:90:"Microfluidic Delivery of Medicine: from point-of-care diagnostics to targeted therapeutics";}i:15;a:3:{s:12:"time_program";s:7:"2:20 pm";s:19:"description_program";s:32:"Frank Jaksch
CEO ChromaDex";s:7:"program";s:99:"The Next Super-Class of Phytochemical Ingredients for Nutraceuticals, Functional Food and Cosmetics";}i:16;a:3:{s:12:"time_program";s:7:"2:40 pm";s:19:"description_program";s:0:"";s:7:"program";s:5:"Break";}i:17;a:3:{s:12:"time_program";s:11:"Session III";s:19:"description_program";s:89:"Moderator: Yan-bo Yang
Director, Pharmaceutical Development, B. Braun Medical Inc.";s:7:"program";s:37:"FDA Regulation of Biomedical Industry";}i:18;a:3:{s:12:"time_program";s:7:"3:00 pm";s:19:"description_program";s:65:"Shepard G. Bentley
RAC, Bentley & Liu Biomedical Consulting";s:7:"program";s:57:"FDA Regulations and Chinese Manufacturers: The Challenges";}i:19;a:3:{s:12:"time_program";s:7:"3:20 pm";s:19:"description_program";s:139:"Jeff Yuen, MPH, MBA.
Previous FDA District Drug Team Leader and Drug Pre-Approval Manager, President and CEO, Jeff Yuen & Associates";s:7:"program";s:50:"Recent FDA Regulatory Trends and Compliance Issues";}i:20;a:3:{s:12:"time_program";s:8:"3: 40 pm";s:19:"description_program";s:64:"Alonza Cruse
Director, Los Angeles District Office, US FDA";s:7:"program";s:73:"A FDA Regulatory (Compliance) Update - A Los Angeles District Perspective";}i:21;a:3:{s:12:"time_program";s:7:"4:25 pm";s:19:"description_program";s:77:"Hengchu Cao, Ph.D.
Edwards Life Ssciences, Past President, SABPA OC/LA";s:7:"program";s:14:"Closing Remark";}}
President, SABPA OC/LA";s:7:"program";s:15:"Opening Remarks";}i:2;a:3:{s:12:"time_program";s:9:"Session 1";s:19:"description_program";s:116:"Moderator: Peter Chen PhD
President, Center for Innovation and Strategic Collaboration, St. Jude Medical, Inc.";s:7:"program";s:28:"Innovation in Medical Device";}i:3;a:3:{s:12:"time_program";s:7:"9:15 am";s:19:"description_program";s:69:"Thomas Yuen
Chairman and CEO, SRS Labs, Biomedical Entrepreneur";s:7:"program";s:90:"Exploring the therapeutic application of stem cell technology: an entrepreneur’s journey";}i:4;a:3:{s:12:"time_program";s:8:"10:00 am";s:19:"description_program";s:69:"Fred Tzeng, PhD
President and Co-founder, ZeroWatt Technologies";s:7:"program";s:65:"Commercialization of University Research by a Former Grad Student";}i:5;a:3:{s:12:"time_program";s:8:"10:20 am";s:19:"description_program";s:0:"";s:7:"program";s:5:"Break";}i:6;a:3:{s:12:"time_program";s:8:"10:40 am";s:19:"description_program";s:96:"Paul Chen, MD
Entrepreneur and Eye Surgeon, North County Laser Eye Associates at San Diego";s:7:"program";s:62:"JET Lasik, accelerating ocular healing by cell transplantation";}i:7;a:3:{s:12:"time_program";s:8:"11:00 am";s:19:"description_program";s:50:"Steve Wheeler
Director of Sales, IDEAL LIFE ";s:7:"program";s:90:"The World-Wide Opportunities for Customized Wireless Monitoring with Real Time Data Access";}i:8;a:3:{s:12:"time_program";s:8:"11:20 am";s:19:"description_program";s:56:"Nadine Ding, PhD
Fellow at Abbott Vascular Devices";s:7:"program";s:87:"Drug Eluting Stent, a Combination Product of Drug and Device and Its Regulatory Pathway";}i:9;a:3:{s:12:"time_program";s:8:"11:40 am";s:19:"description_program";s:0:"";s:7:"program";s:23:"Lunch and Exhibit Booth";}i:10;a:3:{s:12:"time_program";s:10:"Session II";s:19:"description_program";s:80:"Moderator: Jinsong Ni, PhD.
Director, Drug Safety Evaluation, Allergan Inc";s:7:"program";s:8:"Industry";}i:11;a:3:{s:12:"time_program";s:8:"1: 00 pm";s:19:"description_program";s:91:"Edwards Sydney
Senior Director, Portfolio Management and Strategic Planning, Allergan";s:7:"program";s:62:"Global Project & Portfolio Management: The Allergan Experience";}i:12;a:3:{s:12:"time_program";s:7:"1:20 pm";s:19:"description_program";s:51:"Sabing Lee, JD, Knobbe, Martens, Olson & Bear, LLP ";s:7:"program";s:102:"Important Developments in Intellectual Property Affecting the Biomedical and Pharmaceutical Industries";}i:13;a:3:{s:12:"time_program";s:7:"1:40 pm";s:19:"description_program";s:72:"Jerry Hefner, Ph.D., J.D.
Partner, Knobbe Martens Olson & Bear LLP";s:7:"program";s:65:"Potential Changes in the Patentability of Life Science Inventions";}i:14;a:3:{s:12:"time_program";s:7:"2:00 pm";s:19:"description_program";s:76:"Abe Lee
Chair and Professor, Department of Biomedical Engineering, UCI";s:7:"program";s:90:"Microfluidic Delivery of Medicine: from point-of-care diagnostics to targeted therapeutics";}i:15;a:3:{s:12:"time_program";s:7:"2:20 pm";s:19:"description_program";s:32:"Frank Jaksch
CEO ChromaDex";s:7:"program";s:99:"The Next Super-Class of Phytochemical Ingredients for Nutraceuticals, Functional Food and Cosmetics";}i:16;a:3:{s:12:"time_program";s:7:"2:40 pm";s:19:"description_program";s:0:"";s:7:"program";s:5:"Break";}i:17;a:3:{s:12:"time_program";s:11:"Session III";s:19:"description_program";s:89:"Moderator: Yan-bo Yang
Director, Pharmaceutical Development, B. Braun Medical Inc.";s:7:"program";s:37:"FDA Regulation of Biomedical Industry";}i:18;a:3:{s:12:"time_program";s:7:"3:00 pm";s:19:"description_program";s:65:"Shepard G. Bentley
RAC, Bentley & Liu Biomedical Consulting";s:7:"program";s:57:"FDA Regulations and Chinese Manufacturers: The Challenges";}i:19;a:3:{s:12:"time_program";s:7:"3:20 pm";s:19:"description_program";s:139:"Jeff Yuen, MPH, MBA.
Previous FDA District Drug Team Leader and Drug Pre-Approval Manager, President and CEO, Jeff Yuen & Associates";s:7:"program";s:50:"Recent FDA Regulatory Trends and Compliance Issues";}i:20;a:3:{s:12:"time_program";s:8:"3: 40 pm";s:19:"description_program";s:64:"Alonza Cruse
Director, Los Angeles District Office, US FDA";s:7:"program";s:73:"A FDA Regulatory (Compliance) Update - A Los Angeles District Perspective";}i:21;a:3:{s:12:"time_program";s:7:"4:25 pm";s:19:"description_program";s:77:"Hengchu Cao, Ph.D.
Edwards Life Ssciences, Past President, SABPA OC/LA";s:7:"program";s:14:"Closing Remark";}}
Registration (Lunch included):
$30 for pre-registration, $15 for students and post-docs, $40 for onsite registration
SABPA OCLA
